Evidence map›Paper›PMID 26022961›Full record

Trial reportThe European respiratory journal2015

Biomarkers of oxidative stress following continuous positive airway pressure withdrawal: data from two randomised trials.

John R Stradling, Esther I Schwarz, Christian Schlatzer, Ari R Manuel, Regent Lee, Charalambos Antoniades, Malcolm Kohler

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The European respiratory journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 2 pooled it
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 2 syntheses or guidelines pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Review
  8. Letter to the editor relating to Graefe's Arch Clin Exp Ophthalmol 2020 258:939-941. "CPAP therapy reduces oxidative stress in patients with glaucoma and OSAS and improves the visual field".Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2021
    Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Obstructive sleep apnoea in acute coronary syndrome.European respiratory review : an official journal of the European Respiratory Society · 2019
    Review
  14. Obstructive sleep apnoea.Eye (London, England) · 2018
    Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Clinical update sleep: year in review 2015-2016.Journal of thoracic disease · 2016
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

John R StradlingOxford Centre for Respiratory Medicine and NIHR Oxford Biomedical Research Centre, Churchill Hospital Campus, Oxford University, Oxford, UK john.stradling@orh.nhs.uk.
Esther I SchwarzSleep Disorders Centre and Pulmonary Division, University Hospital of Zurich, Zurich, Switzerland.
Christian SchlatzerSleep Disorders Centre and Pulmonary Division, University Hospital of Zurich, Zurich, Switzerland.
Ari R ManuelOxford Centre for Respiratory Medicine and NIHR Oxford Biomedical Research Centre, Churchill Hospital Campus, Oxford University, Oxford, UK.
Regent LeeDivision of Cardiovascular Medicine, Radcliffe Department of Medicine, John Radcliffe Campus, University of Oxford, Oxford, UK.
Charalambos AntoniadesDivision of Cardiovascular Medicine, Radcliffe Department of Medicine, John Radcliffe Campus, University of Oxford, Oxford, UK.
Malcolm KohlerSleep Disorders Centre and Pulmonary Division, University Hospital of Zurich, Zurich, Switzerland.
University Hospital of Zurich · CHUniversity of Oxford · GBChurchill Hospital · GBJohn Radcliffe Hospital · GB

Funding

British Heart Foundation PG/12/80/29891
6 · The paper itself

Abstract

There is conflicting evidence whether intermittent hypoxia in obstructive sleep apnoea (OSA) influences oxidative stress. We hypothesised that withdrawal of continuous positive airway pressure (CPAP) from patients with OSA would raise markers of oxidative stress.59 patients with CPAP-treated moderate-to-severe OSA (oxygen desaturation index (ODI) >20 events·h(-1)) were randomised 1:1 to either stay on CPAP (n=30) or change to sham CPAP (n=29) for 2 weeks. Using samples from two similar studies at two sites, we measured early morning blood malondialdehyde (MDA, a primary outcome in one study and a secondary outcome in the other), lipid hydroperoxides, total antioxidant capacity, superoxide generation from mononuclear cells and urinary F2-isoprostane. We also measured superoxide dismutase as a marker of hypoxic preconditioning. "Treatment" effects (sham CPAP versus CPAP) were calculated via linear regression.Sham CPAP provoked moderate-to-severe OSA (mean ODI 46 events·h(-1)), but blood markers of oxidative stress did not change significantly (MDA "treatment" effect (95% CI) -0.02 (-0.23 to +0.19) μmol·L(-1)). Urinary F2-isoprostane fell significantly by ~30% (-0.26 (-0.42 to -0.10) ng·mL(-1)) and superoxide dismutase increased similarly (+0.17 (+0.02 to +0.30) ng·mL(-1)).We found no direct evidence of increased oxidative stress in patients experiencing a return of their moderate-to-severe OSA. The fall in urinary F2-isoprostane and rise in superoxide dismutase implies that hypoxic preconditioning may have reduced oxidative stress.

Indexed as

Continuous Positive Airway PressureOxidative StressAdultAgedAntioxidantsBiomarkersF2-IsoprostanesFemaleHumansHydrogen PeroxideHypoxiaLeukocytes, MononuclearLinear ModelsLipidsMaleMalondialdehydeAntioxidantsBiomarkersF2-IsoprostanesHydrogen PeroxideLipidsMalondialdehydeOxygenSuperoxide DismutaseSuperoxides

Identifiers

PMID26022961
PMCPMC4579567
OpenAlexW2115209103

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.